glp-1 news updates november 2025 glp-1 news november 3 2025 GLP-1 Therapies May Benefit MPN And MDS Patients glp-1 weight loss drug news

If side effects are severe or persistent, speak to your prescriber

Adults: Take 1 capsule daily between meals

That immediate feedback can accelerate dietary learning and habit change, making Alli useful as a short-term educational tool as well as a modest weight-loss aid

Food and Drug Administration has approved Wegovy (semaglutide) injection to treat metabolic-associated steatohepatitis in adults with excessive scar tissue in the liver

Artificial intelligence, machine and deep learning methodologies can be employed to process and analyze the increasing amount of collected data

Akt2 is required for hepatic lipid accumulation in models of insulin resistance